SCHEMBL3308142

SCHEMBL3308142

CCN(C(=O)S)c1nc2c(s1)C(=O)C(C(=O)c1cccnc1)CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.39
MAPT P10636 5/20 0.38
KDM4E B2RXH2 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 3/20 0.34
LMNA P02545 3/20 0.34
SLC2A1 P11166 1/20 0.34
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
NPSR1 Q6W5P4 3/20 0.33
GFER P55789 2/20 0.33
DUSP3 P51452 1/20 0.33
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
GAA P10253 1/20 0.32
CYP2C19 P33261 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3308151 0.90 HTT (0.40) HTTMAPTKDM4EL3MBTL1MEN1
SCHEMBL3310229 0.88 ALDH1A1 (0.31) ALDH1A1
SCHEMBL3309734 0.82 KDM4E (0.40) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL3277195 0.77 ALDH1A1 (0.47) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL798617 0.75 PIK3CG (0.49) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL10103042 0.75 RAB9A (0.42) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL3273645 0.74 ALDH1A1 (0.47) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL10103040 0.74 ALDH1A1 (0.45) HTTMAPTKDM4EL3MBTL1MEN1
SCHEMBL10111227 0.74 ALDH1A1 (0.45) MAPTKDM4EL3MBTL1MEN1KMT2A
SCHEMBL3277199 0.73 ALDH1A1 (0.46) HTTMAPTKDM4EL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207349-B2 Thiazolyl-dihydro-indazoles BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-26 US disclosed
US-20100113414-A1 THIAZOLYL-DIHYDRO-INDAZOLES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113414-A1 THIAZOLYL-DIHYDRO-INDAZOLES MKI67, CYP11B1, IGF1R HTT 1528/4885MAPT 1919/4885KDM4E 3378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.